The American Journal of Medicine
Volume 121, Issue 12 , Pages 1065-1071 , December 2008

Impact of Changing Definitions for Myocardial Infarction: A Report from the AMIS Registry

  • Philip Urban, MD

      Affiliations

    • Cardiovascular Department, La Tour Hospital, Geneva, Switzerland
    • Corresponding Author InformationRequests for reprints should be addressed to Philip Urban, MD, Cardiovascular Department, La Tour Hospital, 1 Av JD Maillard, Geneva 1217, Switzerland
    • ,
  • Dragana Radovanovic, MD

      Affiliations

    • AMIS Plus Data Center, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    • ,
  • Paul Erne, MD

      Affiliations

    • Cardiology Department, Cantonal Hospital, Luzern, Switzerland
    • ,
  • Jean-Christophe Stauffer, MD

      Affiliations

    • Cardiology Center, Cantonal Hospital, Fribourg, Switzerland
    • ,
  • Giovanni Pedrazzini, MD

      Affiliations

    • Cardiocentro, Lugano, Switzerland
    • ,
  • Stephan Windecker, MD

      Affiliations

    • Cardiology Department, Inselspital, Bern, Switzerland
    • ,
  • Osmund Bertel, MD

      Affiliations

    • Cardio-Vascular Center Zurich, Klinik im Park, Zurich, Switzerland
    • ,
  • AMIS Plus investigators

 Funding: The AMIS Plus registry is funded by unrestricted grants from the Swiss Heart Foundation and from Abbott, Astra-Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Essex/MSD, GlaxoSmithKline, Guidant, INVATEC, Johnson & Johnson – Cordis Division, A Menarini, Medtronic, Mepha Pharma, Merck Sharp & Dohme-Chibret, Novartis, Pfizer, Sanofi-Aventis, Schering, Servier, SPSS, St. Jude Medical, and Takeda Pharma, all in Switzerland.

 Conflict of interest: none.

PII: S0002-9343(08)00843-7

doi: 10.1016/j.amjmed.2008.08.020

The American Journal of Medicine
Volume 121, Issue 12 , Pages 1065-1071 , December 2008

Article Tools

* Image Usage & Resolution